Skip to main content
RankDealDateAmount ($000s) *
1Thalmic Labs raises Series B financing9/19/2016158,172
2DalCor Pharmaceuticals closes Series B financing4/18/2016128,150
3Real Matters completes new financing3/30/2016100,000
4Zymeworks secures series A financing1/8/201686,500
5Hopper secures $82M VC financing deal12/15/201682,000
6Blockstream secures Series A financing2/3/201676,153
7Farmers Edge secures new financing1/27/201658,000
8Turnstone Biologics raises Series B financing11/2/201655,435
9Breather Products secures Series C financing12/5/201653,088
10Buildscale/Vidyard secures Series C financing1/4/201648,892
11Indochino secures $42M strategic investment3/9/201642,000
12MSI Methylation Sciences secures financing10/6/201639,630
13Clearpath Robotics secures financing10/5/201639,534
14Axonify raises US$27M11/1/201636,123
15ecobee completes financing8/18/201635,000

Subscribers can see the top 50 Canadian VC deals here.

Visit The Globe's data store to purchase comprehensive tables from the Canadian Venture Capital & Private Equity Association. Tables include the top venture capital and private equity deals of 2016 and the CVCA's exclusive member list, including detailed metrics and contact information.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.